Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (5624)	11/10/1999 9:31:00 AM
From: Bob Trocchi	Respond to of 5736

Janybird... >>Chromatics Fourth Quarter Shipments in Progress to Ohmeda Medical<< This is a case of looking at a glass half full or half empty depending if you are long or short. On Oct 6, CCSI issued a press release which stated that they completed the shipping of 300 units to Ohmeda. No mention was made at that time of what the size of the contractual commitment was for Q4. The current PR, states that CCSI has shipped half of the q4 commitment on schedule. IMO that is the half full part. My half empty part is that it appears Ohmeda has not increased their commitment thus reflecting a lack of robust sales. If they had you can be sure it would have been reported in the PR. This apparent lack of robust sales again IMO is reflected in the comment which you failed to highlight from the PR. I quote. >><While the distributor's task of gaining market penetration within the domestic medical community will take time to accomplish,<< The implication is that CCSI's products are not flying off the shelf to say the least. Darby does state that these shipments are generating the first substantial revenue for CCSI. I would hope so, last Q they had only $50K (that's thousands) of dollars in revenue! Not very difficult to show a HUGE % increase in revenue when dividing by a number so small. Finally, while it is not stated anywhere that I can find, are these shipments "real?" What I mean by that is can Ohmeda return them in the event they do not sell? It will be interesting to see the A/R line in their next quarterly report. Half full, Half empty time will tell. Regards and good luck. I remain short for my second trip. Bob T

To: JanyBlueEyes who wrote (5624)	11/10/1999 9:47:00 AM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

Bob.......... <<On Oct 6, CCSI issued a press release which stated that they completed the shipping of 300 units to Ohmeda. No mention was made at that time of what the size of the contractual commitment was for Q4>> <<My half empty part is that it appears Ohmeda has not increased their commitment thus reflecting a lack of robust sales. If they had you can be sure it would have been reported in the PR.>> See press release of June 14 - Ohmeda ordered a total of 1030 devices for the 2nd half of 1999: siliconinvestor.com <<The implication is that CCSI's products are not flying off the shelf to say the least.>> Datex-Ohmeda is a well-known highly regarded presence in the hospital and home care market. They are developing a "Total Jaundice Management Program" with the TLc-BiliTest being the highlight of the package. You left this part out from the latest release: ".....we are now seeing the first U.S. hospitals converting to the non-invasive TLc-BiliTest(R) System as their standard of care, representing thousands of babies born each year who will have pain-free monitoring for bilirubin/infant jaundice available in the 21st century"